article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

These innovative procedures offer safe and effective options for high-risk patients who previously had limited or no treatment alternatives, focusing on enhancing quality of life. A TEER procedure, which inserts clips in the valve to reduce leakage, works well for many, but is less effective for those with complex valve anatomy.

article thumbnail

Cancer therapy–related salivary dysfunction

Journal of Clinical Investigation - Cardiology

Consequently, changes in salivary function can profoundly impair quality of life for cancer patients. We discuss salivary gland anatomy and physiology to understand how anticancer therapies such as chemotherapy, bone marrow transplantation, immunotherapy, and radiation therapy impair salivary function.

Cancer 96
article thumbnail

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

Harmony TPV system clinical trials demonstrate ease of implant, conformability to the anatomy, and strong clinical and hemodynamic outcomes for congenital heart disease patients up to three years. Harmony TPV U.S. The device is expected to be commercially available across Europe later this month. 1 Hoffman JL, Kaplan S.

article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges. Engineered for the unique demands of venous anatomy and obstructions, the Duo Venous Stent System is comprised of two stents – Duo Hybrid and Duo Extend – of various sizes. It is the third most common cardiovascular disease [2].

Stents 105
article thumbnail

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

DAIC

Evolut FX+ provides increased space for catheter maneuverability to facilitate access to coronary arteries of varying patient anatomies. The Evolut FX+ TAVR system was designed to facilitate coronary access across a diverse range of patient anatomies with no compromise to valve performance," said Jeffrey Popma, M.D.

TAVR 111
article thumbnail

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

Data from the TRILUMINATE Pivotal trial demonstrated that patients who received TriClip experienced a marked improvement in the severity of their symptoms and quality of life, with benefits sustained at one year. are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S

Tricuspid 105
article thumbnail

Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter

DAIC

1 People suffering from PAD have not only impaired quality of life but also increased risk of heart attack or stroke. PAD affects more than eight million people aged 40 and older in the United States. 2 CLTI is the most advanced and serious form of PAD, impacting nearly 2 million patients in the U.S.